The creation of retatrutide, a novel dual agonist targeting both GLP-1 and GIP receptors, requires a complex several-stage chemical process. Initial routes focused on protein fragment coupling, utilizing solid-phase https://hannaczzk205534.bloginwi.com/74497119/synthesis-and-study-uses-of-retatrutide